All Type of News
Bioequivalence testing of combination products to be made compulsory from 2012
The bioequivalence testing of combined generic medications is expected to be mandatory from 2012 by phases in a bid to ensure their safety and efficacy over original medications, according to the Korea Food and Drug A...
Korea Bone Bank to conduct clinical test over bone morphogenetic protein 2
Korea Bone Bank Corp., a local medical devices maker founded in 1997, said it will carry out a clinical trial on bone morphogenetic protein (BMP2), which stimulates bone formation. Products containing the protein are ...
Choong-wae Med’s direct digital radiography obtains US FDA certification
Local medical device maker Choong-wae Medical Corporation, an affiliated company of Choong-wae Holdings, said on July 29 that its homegrown Direct Digital Radiography (DDR) was certified by the US Food and Drug Admini...
Schering-Plough Korea launches awareness campaign on autoimmune diseases
Schering-Plough Korea is spearheading a new educational campaign “Hope Story” to raise awareness about autoimmune diseases, such as rheumatoid arthritis, Crohn's disease and spondylitis, along with 23 university hospi...
Government to sweep pharmaceutical industry
The government will step up its fight against chronic illegal rebate practices whereby doctors and pharmacists receive money from drug makers in return for prescribing or recommending their products, according to the ...
Dapoxetine approved for treatment of premature ejaculation
The Korea Food and Drug Administration said on June 28 it has given a green light to Priligy (dapoxetine) for the treatment of premature ejaculation (PE) in men, according to Janssen Korea.
Dapoxetine, an selective...
Doctors allowed to dispense Tamiflu
Doctors or dental doctors will be allowed to directly dispense drugs to treat contagious diseases, such as Tamiflu and Relenza at state-designated hospitals, the Ministry of Health, Welfare and Family Affairs said on ...
NovoSeven to benefit from health insurance
The health ministry announced on July 27 that the insurance price of Novo Nordisk’s NovoSeven 60KIU will increase to 1.2 million won from 929,674 won from next month.
The government said on July 21 that the insuran...
Vytorin price to be lowered by 32.8%
MSD Korea said the insurance price of its lipid-lowering agent Vytorin 10 mg (ezetimibe/simvastatin) will be reduced by 32.8% by next January upon its voluntary decision.
A company official said this price cut may ...
KFDA to strengthen ADR monitoring
The Korea Food and Drug Administration has unveiled its plan to step up the function of adverse drug reaction system
Korea had the lowest reporting rate on drug related side effects – 20 cases per 1 million people,...
